Literature DB >> 2375278

The role of the mesenchyme in mouse neural fold elevation. I. Patterns of mesenchymal cell distribution and proliferation in embryos developing in vitro.

J Morris-Wiman1, L L Brinkley.   

Abstract

Using the computer-assisted method of smoothed spatial averaging, spatial and temporal patterns of cell distribution and mitotic activity were analyzed in the cranial mesenchyme underlying the mesencephalic neural folds of mouse embryos maintained in roller tube culture. Total cell density increased in central and medial mesenchymal regions after 12 hr in culture, decreased after 18 hr, and showed a further decrease after 24 hr when the neural folds of the embryos had elevated, converged, and were fusing or fused. Mitotic activity, as measured by the ratio of 3H-thymidine-labeled cells to unlabeled cells, was highest in the central mesenchyme at all culture times. Embryos were also cultured in the presence of diazo-oxo-norleucine (DON), which inhibits glycosaminoglycan and glycoprotein synthesis. After 24 hr in culture, neural folds of DON-treated embryos had failed to elevate. Total cell density increased in central and medial regions of the mesenchyme of DON-treated folds at 12 hr but showed no significant decrease in these regions with further culture. Mitotic activity was highest in the central mesenchyme of these treated embryos. These results suggest that cell distribution patterns observed in the cranial mesenchyme during neural fold elevation in normal cultured embryos are not produced by regional differences in mitotic activity. Rather, we propose that cell distribution patterns in the central and medial regions of the mesenchyme result from expansion of a glycosaminoglycan-rich extracellular matrix that disperses cells from these regions and decreases their density. In DON-treated embryos, in which expansion of the mesenchyme is prohibited by the decreased glycosaminoglycan and glycoprotein content of the extracellular matrix, mitotic activity apparently determines these patterns.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375278     DOI: 10.1002/aja.1001880203

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  4 in total

1.  Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density.

Authors:  Minhye Shin; Amanda Vaughn; Jessica Momb; Dean R Appling
Journal:  Birth Defects Res       Date:  2019-09-13       Impact factor: 2.344

Review 2.  Does the cranial mesenchyme contribute to neural fold elevation during neurulation?

Authors:  Irene E Zohn; Anjali A Sarkar
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-09-03

3.  Hectd1 regulates intracellular localization and secretion of Hsp90 to control cellular behavior of the cranial mesenchyme.

Authors:  Anjali A Sarkar; Irene E Zohn
Journal:  J Cell Biol       Date:  2012-03-19       Impact factor: 10.539

4.  An explant assay for assessing cellular behavior of the cranial mesenchyme.

Authors:  Anjali A Sarkar; Irene E Zohn
Journal:  J Vis Exp       Date:  2013-01-20       Impact factor: 1.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.